Enorama Pharma AB
556716-5591ActiveSwedish pharmaceutical company developing oral nicotine cessation products.
Pharmaceutical Company / Life Science Companyenorama.se
Overview
- 5–9
- Employees
- 5–10M SEK
- Revenue
- 2006
- Founded
Key Decision Makers
Bengt Jönsson
Acting CEO and Chairman of the Board
@enorama.se
Daniel Schröder
CEO
@enorama.se
Fredrik Olsson
Board Member
@enorama.se
Mikael Åbom
Board Member
@enorama.se
+2 more contacts in Funnelfeedr
Description
Enorama Pharma AB is an innovative Swedish pharmaceutical company listed on the Nasdaq First North Growth Market. The core focus of the organization is the development and commercialization of consumer-friendly, oral nicotine products aimed at reducing or eliminating tobacco use. They market premium...